These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O'Riordan CR. Hum Gene Ther; 1999 Nov 01; 10(16):2615-26. PubMed ID: 10566889 [Abstract] [Full Text] [Related]
23. Manipulation of the cytoplasmic and transmembrane domains alters cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection. van't Hof W, Crystal RG. Hum Gene Ther; 2001 Jan 01; 12(1):25-34. PubMed ID: 11177539 [Abstract] [Full Text] [Related]
27. The role of the extracellular domain in the biology of the coxsackievirus and adenovirus receptor. Excoffon KJ, Traver GL, Zabner J. Am J Respir Cell Mol Biol; 2005 Jun 01; 32(6):498-503. PubMed ID: 15778494 [Abstract] [Full Text] [Related]
30. The PDZ1 and PDZ3 domains of MAGI-1 regulate the eight-exon isoform of the coxsackievirus and adenovirus receptor. Kolawole AO, Sharma P, Yan R, Lewis KJ, Xu Z, Hostetler HA, Ashbourne Excoffon KJ. J Virol; 2012 Sep 01; 86(17):9244-54. PubMed ID: 22718816 [Abstract] [Full Text] [Related]
31. Herpes virus infection of RPE and MDCK cells: polarity of infection. Topp KS, Rothman AL, Lavail JH. Exp Eye Res; 1997 Mar 01; 64(3):343-54. PubMed ID: 9196385 [Abstract] [Full Text] [Related]
33. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M, Stevenson SC. J Virol; 2002 Feb 01; 76(4):1892-903. PubMed ID: 11799184 [Abstract] [Full Text] [Related]
34. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Granio O, Ashbourne Excoffon KJ, Henning P, Melin P, Norez C, Gonzalez G, Karp PH, Magnusson MK, Habib N, Lindholm L, Becq F, Boulanger P, Zabner J, Hong SS. Hum Gene Ther; 2010 Mar 01; 21(3):251-69. PubMed ID: 19788389 [Abstract] [Full Text] [Related]
35. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Pedersen E, Crystal RG. Am J Respir Cell Mol Biol; 1999 Mar 01; 20(3):361-70. PubMed ID: 10030833 [Abstract] [Full Text] [Related]
36. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity. Yun CO, Yoon AR, Yoo JY, Kim H, Kim M, Ha T, Kim GE, Kim H, Kim JH. Hum Gene Ther; 2005 Feb 01; 16(2):248-61. PubMed ID: 15761264 [Abstract] [Full Text] [Related]
37. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Farmen SL, Karp PH, Ng P, Palmer DJ, Koehler DR, Hu J, Beaudet AL, Zabner J, Welsh MJ. Am J Physiol Lung Cell Mol Physiol; 2005 Dec 01; 289(6):L1123-30. PubMed ID: 16085675 [Abstract] [Full Text] [Related]